Table 5.

circRNAs and esophageal cancer

CircRNAs	Dysregulation	Target	Model (In vitro, in vivo, Human)	Type of cell line	Ref
circPVT1	Up	Paxs, PPARs	Human, In vitro	EC109, CaES-17, TE-1, TE-10,HEEC, HepG2, MKN45, SW60, A549	(Zhong et al., 2019)
hsa_circ_0006168, miR-100	Down		Human, In vitro	TE13, ECA109, Kyse150, Kyse450, Kyse510, Het-1A	(Shi et al., 2019)
Hsa_circ_0004370	Up	miR-1294/LASP1 pathway	Human, In vitro	Eca-109,TE-1, KYSE-150, Het-1A	(Zhang, Z. et al., 2019)
CircRNA_000543	Up	miR-9	Human, In vitro	NPC, CNE1, 5e8F	(Chen, L. et al., 2019)
has_circ_0067934	Up		Human, In vitro	TE-13, KYSE-410, ECA-109, TE-1, HEEC	(Xia et al., 2016)
circ-SMAD7	Up		Human, In vitro	KYSE30, KYSE 70, KYSE 140, KYSE 150, KYSE 180, TE10, TE12, HET-1-A	(Zhang, Y. et al., 2019)
ITCH	-	Wnt/β-catenin pathway	Human, In vitro	Eca-109, TE-1	(Li, F. et al., 2015)
Circ-TTC17	Up		Human, In vitro	HET-1A, KYSE30, KYSE450	(Wang, Q. et al., 2019)